Paul Malenchini - Hologic Chief Officer

HO1 Stock  EUR 75.50  1.00  1.34%   

Insider

Paul Malenchini is Chief Officer of Hologic
Phone508 263 2900
Webhttps://www.hologic.com

Hologic Management Efficiency

The company has return on total asset (ROA) of 0.0858 % which means that it generated a profit of $0.0858 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.206 %, meaning that it generated $0.206 on every $100 dollars invested by stockholders. Hologic's management efficiency ratios could be used to measure how well Hologic manages its routine affairs as well as how well it operates its assets and liabilities.
Hologic has accumulated 2.81 B in total debt with debt to equity ratio (D/E) of 134.0, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Hologic has a current ratio of 1.64, which is within standard range for the sector. Debt can assist Hologic until it has trouble settling it off, either with new capital or with free cash flow. So, Hologic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hologic sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hologic to invest in growth at high rates of return. When we think about Hologic's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Jan WickeTalanx AG
55
Fei WangOrigin Agritech
40
Robert DeSantisIntuitive Surgical
57
Rick CarronSuperior Plus Corp
N/A
James DevensSuperior Plus Corp
N/A
FCA FCASuperior Plus Corp
68
Fredrik WidmanIntuitive Surgical
N/A
Torsten LeueTalanx AG
57
Amir KhoshniyatiIdentiv
N/A
Edgar PulsTalanx AG
50
Bjorn NorrbomSIVERS SEMICONDUCTORS AB
72
Yasheng YangOrigin Agritech
51
Caroline SchlienkampTalanx AG
49
Marshall MohrIntuitive Surgical
67
Geoffery MerszeiOrigin Agritech
68
Robert SmithNMI Holdings
53
Jamie SamathIntuitive Surgical
52
Norman FitzgeraldNMI Holdings
56
David BullockOrigin Agritech
49
MBA MBASuperior Plus Corp
70
James KangOrigin Agritech
54
Hologic, Inc., a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company was founded in 1985 and is headquartered in Marlborough, Massachusetts. HOLOGIC INC is traded on Frankfurt Stock Exchange in Germany. Hologic (HO1) is traded on Frankfurt Exchange in Germany and employs 6,944 people.

Management Performance

Hologic Leadership Team

Elected by the shareholders, the Hologic's board of directors comprises two types of representatives: Hologic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hologic. The board's role is to monitor Hologic's management team and ensure that shareholders' interests are well served. Hologic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hologic's outside directors are responsible for providing unbiased perspectives on the board's policies.
Paul Malenchini, Chief Officer
Mike Kelly, Chief Affairs
Stephen MacMillan, CEO Chairman
Jan Verstreken, Group International
Kevin Thornal, Group Solutions
Ryan Simon, VP Relations
Karleen Oberton, Chief Officer
Monica Berthelot, VP Staff
Elisabeth Hellmann, Sr Communications
John Griffin, G Counsel

Hologic Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hologic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Hologic Stock

When determining whether Hologic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hologic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hologic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hologic Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Hologic Stock please use our How to Invest in Hologic guide.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Please note, there is a significant difference between Hologic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hologic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hologic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.